Warning! GuruFocus detected
2 Severe warning signs
with RPH.
Try a 7-Day Free Trial
to check it out.
What is a stock summary page? Click here for an overview.
Business Description
SC Ropharma SA
NAICS : 446110
SIC : 5912
ISIN : ROIAFRACNOR4
Compare
Compare
Traded in other countries / regions
RPH.Romania IPO Date
1997-01-13Description
SC Ropharma SA is engaged in the production, distribution, and Retail sale of pharmaceutical products in specialized stores. Its product portfolio comprises over 50 products in the form of tablets, powders, capsules, and syrups covering 21 therapeutic areas.
Financial Strength
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.2 | |||||
| Equity-to-Asset | 0.27 | |||||
| Debt-to-Equity | 0.7 | |||||
| Debt-to-EBITDA | 3.48 | |||||
| Interest Coverage | 3.73 | |||||
| Piotroski F-Score | 6/9 | |||||
| Altman Z-Score | 1.5 | |||||
| Beneish M-Score | -2.7 | |||||
| WACC vs ROIC | ||||||
Growth Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 11.9 | |||||
| 3-Year EBITDA Growth Rate | 12 | |||||
| 3-Year EPS without NRI Growth Rate | -16.7 | |||||
| 3-Year Book Growth Rate | 6.6 |
Momentum Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 14.28 | |||||
| 9-Day RSI | 26.84 | |||||
| 14-Day RSI | 34.64 | |||||
| 3-1 Month Momentum % | -13.29 | |||||
| 6-1 Month Momentum % | -15.73 | |||||
| 12-1 Month Momentum % | -21.05 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.01 | |||||
| Quick Ratio | 0.61 | |||||
| Cash Ratio | 0.06 | |||||
| Days Inventory | 70.89 | |||||
| Days Sales Outstanding | 87.01 | |||||
| Days Payable | 154.82 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -0.1 | |||||
| Shareholder Yield % | -24.93 |
Profitability Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 14.6 | |||||
| Operating Margin % | 2.08 | |||||
| FCF Margin % | 2.43 | |||||
| ROE % | 0.01 | |||||
| ROA % | 0.98 | |||||
| ROIC % | 1.77 | |||||
| 3-Year ROIIC % | 8.18 | |||||
| ROC (Joel Greenblatt) % | 6.75 | |||||
| ROCE % | 5.91 | |||||
| Years of Profitability over Past 10-Year | 10 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 10.33 | |||||
| PE Ratio without NRI | 14.09 | |||||
| Shiller PE Ratio | 7.21 | |||||
| Price-to-Owner-Earnings | 3.97 | |||||
| PEG Ratio | 1.14 | |||||
| PS Ratio | 0.07 | |||||
| PB Ratio | 0.33 | |||||
| Price-to-Tangible-Book | 0.41 | |||||
| Price-to-Free-Cash-Flow | 3.1 | |||||
| Price-to-Operating-Cash-Flow | 1.76 | |||||
| EV-to-EBIT | 10.7 | |||||
| EV-to-EBITDA | 4.66 | |||||
| EV-to-Revenue | 0.21 | |||||
| EV-to-FCF | 8.77 | |||||
| Price-to-GF-Value | 0.48 | |||||
| Price-to-Projected-FCF | 3.63 | |||||
| Price-to-DCF (Earnings Based) | 1.04 | |||||
| Price-to-DCF (FCF Based) | 0.23 | |||||
| Price-to-Median-PS-Value | 0.25 | |||||
| Price-to-Peter-Lynch-Fair-Value | 1.04 | |||||
| Price-to-Graham-Number | 0.48 | |||||
| Earnings Yield (Greenblatt) % | 9.34 | |||||
| FCF Yield % | 35.01 | |||||
| Forward Rate of Return (Yacktman) % | 1.1 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
SC Ropharma SA Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil lei) | 1,067.137 | ||
| EPS (TTM) (lei) | 0.015 | ||
| Beta | 0.05 | ||
| 3-Year Sharpe Ratio | -1 | ||
| 3-Year Sortino Ratio | -1.19 | ||
| Volatility % | 10.67 | ||
| 14-Day RSI | 34.64 | ||
| 14-Day ATR (lei) | 0.005195 | ||
| 20-Day SMA (lei) | 0.15475 | ||
| 12-1 Month Momentum % | -21.05 | ||
| 52-Week Range (lei) | 0.145 - 0.218 | ||
| Shares Outstanding (Mil) | 511.27 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 6 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
SC Ropharma SA Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
SC Ropharma SA Stock Events
| Event | Date | Price (lei) | ||
|---|---|---|---|---|
| No Event Data | ||||
SC Ropharma SA Frequently Asked Questions
What is SC Ropharma SA(BSE:RPH)'s stock price today?
The current price of BSE:RPH is lei0.14. The 52 week high of BSE:RPH is lei0.22 and 52 week low is lei0.14.
When is next earnings date of SC Ropharma SA(BSE:RPH)?
The next earnings date of SC Ropharma SA(BSE:RPH) is .
Does SC Ropharma SA(BSE:RPH) pay dividends? If so, how much?
SC Ropharma SA(BSE:RPH) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers